In the webinar Winlow talks about the US P3 trials that were...

  1. 639 Posts.
    lightbulb Created with Sketch. 95
    In the webinar Winlow talks about the US P3 trials that were also successful. If those results were so successful why haven't the regulators legalised the supervised use of MDMA to treat PTSD in the US? We all know the major SP catalyst for biotechs is FDA approval, but there is no chance of that for at least 5 years according to Winlow. There is also no suggestion from other regulators that they will legalise MDMA use. My guess is that's why the share prices hasn't moved much off these good results.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $16.50M
Open High Low Value Volume
2.7¢ 2.8¢ 2.6¢ $29.59K 1.096M

Buyers (Bids)

No. Vol. Price($)
2 4919 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 1363075 5
View Market Depth
Last trade - 13.02pm 01/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.